Jane Street
EVH icon

Jane Street’s Evolent Health EVH Stock Holding History

Jane Street’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$419K Buy
77,300
+60,900
+371% +$233K ﹤0.01% 8434
2026
Q1 		$37.4K Buy
16,400
+2,700
+20% +$8.56K ﹤0.01% 11063
2025
Q4 		$54.8K Buy
+13,700
New +$76.2K ﹤0.01% 10477
2025
Q2 		– Sell
-33,500
Closed -$317K – 9955
2025
Q1 		$317K Sell
33,500
-34,500
-51% -$348K ﹤0.01% 7707
2024
Q4 		$765K Sell
68,000
-181,700
-73% -$3.19M ﹤0.01% 5896
2024
Q3 		$7.06M Buy
+249,700
New +$6.44M ﹤0.01% 2343
2024
Q2 		– Sell
-34,300
Closed -$1.12M – 9569
2024
Q1 		$1.12M Buy
34,300
+18,800
+121% +$600K ﹤0.01% 5202
2023
Q4 		$512K Buy
+15,500
New +$439K ﹤0.01% 6719
2023
Q2 		– Sell
-6,800
Closed -$221K – 8896
2023
Q1 		$221K Sell
6,800
-15,500
-70% -$490K ﹤0.01% 7705
2022
Q4 		$626K Sell
22,300
-8,500
-28% -$244K ﹤0.01% 5748
2022
Q3 		$1.11M Buy
30,800
+18,100
+143% +$638K ﹤0.01% 5233
2022
Q2 		$390K Sell
12,700
-1,800
-12% -$52.5K ﹤0.01% 7172
2022
Q1 		$468K Sell
14,500
-24,700
-63% -$647K ﹤0.01% 7617
2021
Q4 		$1.08M Sell
39,200
-92,000
-70% -$2.64M ﹤0.01% 5730
2021
Q3 		$4.07M Buy
131,200
+113,700
+650% +$2.73M ﹤0.01% 3077
2021
Q2 		$370K Sell
17,500
-6,700
-28% -$134K ﹤0.01% 7801
2021
Q1 		$489K Buy
24,200
+8,800
+57% +$167K ﹤0.01% 6844
2020
Q4 		$247K Buy
+15,400
New +$204K ﹤0.01% 6679

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Jane Street's EVH Position: Q2 2026 in Review

Jane Street sold out of Evolent Health (EVH) in Q2 2026, closing a stake of 1,790,147 shares — an estimated $6.86M sold.

Jane Street first reported a position in EVH in Q1 2017 and held it in 28 quarters. The position peaked at $12.2M in Q3 2025. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Jane Street reported no remaining Evolent Health position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 1,790,147 Evolent Health shares in Q2 2026, an estimated $6.86M.
  • Jane Street first reported a position in Evolent Health in Q1 2017 and held it in 28 quarters.
  • Jane Street's Evolent Health position peaked at $12.2M in Q3 2025.
  • 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.